LCM
ABBV icon

Laurion Capital Management’s AbbVie ABBV Stock Holding History

Laurion Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,055,000
Closed -$244M – 307
2025
Q3 		$244M Buy
+1,055,000
New +$215M 4.2% 3
2024
Q3 		– Sell
-80,000
Closed -$13.7M – 281
2024
Q2 		$13.7M Buy
+80,000
New +$13.3M 0.16% 94
2023
Q2 		– Sell
-150,000
Closed -$23.9M – 586
2023
Q1 		$23.9M Sell
150,000
-850,000
-85% -$130M 0.16% 125
2022
Q4 		$162M Buy
+1,000,000
New +$153M 0.76% 42
2022
Q2 		– Sell
-20,200
Closed -$3.27M – 458
2022
Q1 		$3.27M Sell
20,200
-62,400
-76% -$9.06M 0.04% 178
2021
Q4 		$11.2M Sell
82,600
-213,300
-72% -$25.2M 0.11% 119
2021
Q3 		$31.9M Buy
+295,900
New +$33.8M 0.13% 154
2020
Q2 		– Sell
-126,700
Closed -$9.65M – 876
2020
Q1 		$9.65M Sell
126,700
-237,000
-65% -$20.2M 0.11% 179
2019
Q4 		$32.2M Sell
363,700
-382,200
-51% -$31.7M 0.25% 93
2019
Q3 		$56.5M Buy
745,900
+369,200
+98% +$25.3M 0.42% 54
2019
Q2 		$27.4M Buy
376,700
+358,700
+1,993% +$28.2M 0.27% 89
2019
Q1 		$1.45M Sell
18,000
-73,800
-80% -$6.04M 0.02% 451
2018
Q4 		$8.46M Sell
91,800
-474,000
-84% -$41.7M 0.15% 176
2018
Q3 		$53.5M Buy
565,800
+58,200
+11% +$5.52M 0.52% 20
2018
Q2 		$47M Buy
507,600
+30,500
+6% +$2.98M 0.38% 58
2018
Q1 		$45.2M Sell
477,100
-65,000
-12% -$7.14M 0.36% 63
2017
Q4 		$52.4M Buy
542,100
+222,100
+69% +$20.9M 0.27% 79
2017
Q3 		$28.4M Sell
320,000
-58,800
-16% -$4.48M 0.13% 140
2017
Q2 		$27.5M Buy
378,800
+104,200
+38% +$7.01M 0.15% 133
2017
Q1 		$17.9M Buy
274,600
+154,500
+129% +$9.71M 0.13% 189
2016
Q4 		$7.52M Buy
+120,100
New +$7.33M 0.07% 274

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Laurion Capital Management's ABBV Position: Q1 2026 in Review

Laurion Capital Management opened a new position in AbbVie (ABBV) in Q1 2026: 8,395 shares worth $1.83M. The stake represents 0.08% of the portfolio and ranks #221 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in ABBV as recently as Q2 2024.

Laurion Capital Management first reported a position in ABBV in Q2 2015 and has held it in 21 quarters since. The position peaked at $49.5M in Q2 2016. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Laurion Capital Management held 8,395 shares of AbbVie worth $1.83M as of Q1 2026.
  • AbbVie was a new Laurion Capital Management position in Q1 2026.
  • AbbVie made up 0.08% of Laurion Capital Management's portfolio in Q1 2026, its #221 holding.
  • Laurion Capital Management first reported a position in AbbVie in Q2 2015 and has held it in 21 quarters since.
  • Laurion Capital Management's AbbVie position peaked at $49.5M in Q2 2016.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.